Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

11 April 2017 : Original article  

Application of Indocyanine Green (ICG) Detection in Evaluating Early Prognosis in Patients with Fatty Liver Disease After Liver Transplantation

Wenjing Wang1ABDEF, Qiang Zhao1CF, Anbin Hu1EF, Xiaoshun He1A, Xiaofeng Zhu1AE*

DOI: 10.12659/AOT.901277

Ann Transplant 2017; 22:208-214

Abstract

BACKGROUND: The relationship between the clearance rate of ICG (indocyanine green) and varying degrees of liver fatty degeneration remains to be explored. The value of ICG detection in the evaluation of early prognosis following hepatic transplantation has been rarely investigated.

MATERIAL AND METHODS: Clinical data of 106 patients undergoing liver transplantation were retrospectively analyzed. The severity of fatty degeneration of the resected liver specimens was assessed by pathological biopsy. All patients were assigned into one of three groups: A (no fatty degeneration), B (<20% hepatic fatty degeneration) or C (20–40% hepatic fatty degeneration). Multiple parameters were statistically compared among the three groups before, during, and after liver transplantation.

RESULTS: The results demonstrated that R15-D (15 minute detection rate of ICG in the donors) was positively correlated with R15-R (15 minute detection rate of ICG in the recipients). After liver transplantation, the peak values of ALT and total bilirubin (TB), and the R15-R and the rate of early allograft dysfunction (EAD) in group C were the highest among all three groups. However, the 3-month and 6-month survival rate of the grafts and the 1-year survival rate of the patients in group A were considerably lower compared to groups B and C. The area under the curve (AUC) of R15-R in predicting the EAD, 3-month survival rate and 6-month survival rate of the grafts and the 1-year survival rate of the patients was 0.956, 0.827, 0.867, and 0.794, respectively.

CONCLUSIONS: ICG detection rate can be used to predict the early prognosis of patients diagnosed with moderate liver fatty degeneration.

Keywords: Lipid Peroxides, Liver Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358